Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | VIKING THERAPEUTICS INC | $3.34B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EQT | EQT CORP | $32.49B | 1.26% | 12.10% | $0.1650 | $0.65 | 29% | 0 | ||
| BNTX | BIONTECH SE | $21.73B | N/A | 0.00% | $2.1110 | N/A | N/A | 0 | ||
| SLDB | SOLID BIOSCIENCES INC | $702.93M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PCVX | VAXCYTE INC | $6.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $841.98M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HIVE | HIVE DIGITAL TECHNOLOGIES LTD | $997.52M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $336.44M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ODTX | ODYSSEY THERAPEUTICS INC | N/A | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KLRA | KAILERA THERAPEUTICS INC | $2.45B | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.